Soluble complexes of amylod β peptide and peptidyl prolyl isomerase chaperone and methods of making and using them
AssigneeRoche Diagnostics GmbH
InventorsChristian Scholz, Elke Faatz, Peter Schaarschmidt
Life of this patent
Estimating the term…
Abstract
The present invention relates to the diagnosis of Alzheimer's Disease. It especially teaches the production of a soluble Aβ-chaperone complex and the advantageous use of such chaperone-Aβ complex, especially in the detection of Aβ in an immunoassay, as well as its use as an immunogen.
Claims53
A protein which is soluble to at least 100 nM in a solution which has a pH of 7.4 and consists of 20 nM sodium phosphate and 150 nM sodium chloride, said protein comprising:
- an amyloid β(Aβ) peptide, and
- a peptidyl prolyl isomerase chaperone,
- wherein the PrP and the peptidyl prolyl isomerase chaperone are covalently linked.
A recombinant polypeptide which is soluble to at least 100 nM in a solution which has a pH of 7.4 and consists of 20 nM sodium phosphate and 150 nM sodium chloride, said recombinant polypeptide comprising:
- an amyloid β(Aβ) peptide,
- a peptidic linker, and
- a peptidyl prolyl isomerase chaperone.
A recombinantly-produced fusion polypeptide comprising:
- an amyloid β(Aβ) peptide, and
- an FKBP chaperone polypeptide, wherein said FKBP chaperone polypeptide is selected from the group consisting of FkpA, SlyD, and trigger factor.
An expression vector comprising:
- at least one nucleic acid sequence encoding an amyloid β(Aβ) peptide,
- at least one nucleic acid sequence encoding a peptidic linker, and
- at least one nucleic acid sequence encoding an FKBP chaperone selected from the group consisting of FkpA, SlyD, and trigger factor.
A method for producing a soluble amyloid β(Aβ) peptide-chaperone protein comprising:
- incubating a protein comprising Aβ peptide covalently linked to a peptidyl prolyl isomerase chaperone in a nonphysiological buffer wherein both the Aβ peptide and the chaperone are solubilized, and
- adjusting the buffer to physiological conditions wherein the Aβ-chaperone protein formed is soluble to at least 100 nM, said buffer at physiological conditions comprising a pH of 7.4, 20 mM sodium phosphate, and 150 mM sodium chloride.
Dependencies are inferred from the claim text.